SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1502 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Min  Hr  Day  Wk  Mon  Yr  3 Yr  Log
Introduction Market Data Compact
IBRX 8.390+7.3%Mar 13 9:30 AM EDT
Top Headlines - ImmunityBio, Inc.
Best Biotech Stocks To Research – March 13th 5 AM
BTIG Research Initiates Coverage on ImmunityBio (NASDAQ:IBRX) yesterday
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 last Friday
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 last Friday
ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 last Friday
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1502Wouldn't PSS be up for a deal with a Biggie where they'd take over adminwaitwatchwander-11 AM
1501Ha ha. To Life !! I’m rooting for a similar result as IMMU, that being that a galt-11 AM
1500Trust me, I'm right with you on the desire to stay vertical for a while longFitzhughlaw111 AM
1499Yes, and follow this up by going around the back of those high level bureaucratgalt110 AM
1498Nice shout out from PSS to Huggenberg for his explanation of the Leonardo platfoCCS6485last Friday
1497IBRX Update: ImmunityBio Achieves Milestone with Large-Scale NK Cell ProducDavidoff6last Friday
1496Thanks! Nice summary.erippetoe-last Thursday
1495a little about this analyst, since this is "new" coverage: AI Overvieluckydog882last Thursday
1494BTIG Assumes ImmunityBio at Buy, Announces Price Target of $13 BENZINGA Mar-12-luckydog884last Thursday
1493Citizens Life Sciences presentation today at 4:35 eastern event.summitcast.comerippetoe-last Wednesday
1492"How does this happen." It happens because far too many citizens haveFitzhughlaw6last Tuesday
1491Zag, You are probably right, but this FDA performance is a disgrace. They alrebobbseytwins20018last Monday
1490 Probable timeline Receipt acknowledged Immediate (March 9, 2026) Fzagnut11last Monday
1489ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA&#luckydog886last Monday
1488I do think that there are other requirements needed to be a part of the cabal… galt4last Sunday
1487I don’t see how gutting cancer research funding and purging scientists and doctodorightbythem3last Sunday
1486I think it’s very positive overall and have to imagine it can only help IBRX.erippetoe1March 7
1485Anyone has an opinion on Dr. Prasad leaving FDA and implication on IBRX?Interesting Times1March 7
1484Piper Sandler Reiterates Overweight on ImmunityBio, Raises Price Target to $12 Bluckydog881March 4
1483Link for today's webcast at 4:30 EST ir.immunitybio.comerippetoe-March 3
1482The filing in December 2025 allowed for up to $459 million of at the money stockMaturin1March 3
1481They had better be announcing an ATM withdrawal at the current advantageous markghettogoulash-March 3
1480So far so good with today’s trading. The shorts seem to be in a box with a loomjargonweary5March 2
1479The Leonardo Apheresis Platform Interesting write up by Huggenberg huggenberg.serippetoe4March 1
1478Bret Baier interview with dr Patrick Soon Shong instagram.comzagnut1-March 1
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News